SARS-CoV-2 May Become Resistant, Mutate After Sotrovimab Treatment

Patients who receive one of the few antibody treatments that works against the Omicron variant must be carefully monitored because, after the drug is infused, the virus may mutate and become resistant to it, researchers warn.
Reuters Health Information

source https://www.medscape.com/viewarticle/970180?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost